Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

The Autoinjectors Market is expected to witness a growth rate of 14-16% by 2028. The key factors driving the market are the ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...

Gov. Mike Braun visited Lebanon Tuesday to help break ground for the $4.5 billion Eli Lilly Medicine Foundry in Lebanon. The foundry is the first research and development site of its kind in the world ...

With more health systems under increasing financial strain and AI adoption on the rise, Iodine is one of the few healthcare AI companies delivering clear, quantifiable results. A recent McKinsey ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...

Swiss pharmaceutical giant Roche announced today that it plans to invest 2.04 billion yuan (about $283M) in building a new ...

5:54 PM UTC · Updated ago Boards, Policy & Regulationcategory Eli Lilly's Zepbound outperforms Novo ... wind project warned ...

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Houston-based Empower Pharmacy has rapidly expanded over the past decade. Now a competitor is suing Empower, alleging its ...